Arrowhead Pharmaceuticals, Inc.
2020 Q2 - 2026 Q1 (12 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q1 | 5/15/2026 | 66,245 | 0.7% | 1,056,534 | 3/31/2026 |
| 2022 Q4 | 2/14/2023 | 15,139 | 0.6% | 373,254 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 12,282 | 0.5% | 371,623 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 12,795 | 0.5% | 363,379 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 15,870 | 0.5% | 345,085 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 22,421 | 0.7% | 338,171 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 21,147 | 0.7% | 338,734 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 29,160 | 0.9% | 352,089 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 23,678 | 0.8% | 357,082 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 30,175 | 1.0% | 393,263 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 16,589 | 0.7% | 385,259 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 18,318 | 0.8% | 424,128 | 6/30/2020 |